Mike Flanagan

Outlook Vimeo Google Tag Manager WordPress.org YouTube Typekit Nginx Varnish reCAPTCHA Mobile Friendly Remote

drug discovery & development nucleic acids rna rare disease biotechnology: pharmaceutical preparations health care avidity biosciences rna therapeutics antibody oligonucleotide conjugates aoc platform monoclonal antibodies oligonucleotide therapies myotonic dystrophy duchenne muscular dystrophy facioscapulohumeral muscular dystrophy gene therapy clinical trials targeted delivery sirna pmo muscle disease therapeutic development drug delivery neuromuscular disorders unmet medical needs orphan diseases fast-track designation breakthrough therapy designation precision cardiology immunology pipeline programs investigational therapies safety profile pharmacodynamics pharmacokinetics patient outcomes disease progression genetic drivers clinical efficacy aoc candidates patient-centric approach biopharmaceutical drug development process molecular therapies cellular targeting target validation research collaborations biological assays regulatory approval clinical efficacy studies biomarker analysis healthcare outcomes long-term safety monitoring rare muscle diseases targeted therapies genetic disorders innovative treatments clinical development healthcare solutions disease-specific therapies biotechnology industry therapeutic pipeline drug development genetic therapies biopharmaceuticals healthcare innovation targeted rna delivery muscle tissue targeting oligonucleotide precision ethical research compassionate care health wellness & fitness hospital & health care